Other Required Committee Review/Approvals - IBC

Institutional Biosafety Committee (IBC)

If your research involves recombinant DNA, infectious agents, and/or human gene transfer/therapy products, the Institutional BioSafety Committee (IBC) will need to review and provide provisional approval for your research prior to approval of your IRB application (Please note, SOME vaccine trials also require IBC review and approval. You may contact the Biological Safety Officer to help you make that determination, 859-257-1049). For research involving human gene transfer (HGT), see the Guidance for Conducting Human Gene Transfer Research at UK [PDF].

In the Other Review Committees section of your E-IRB application, check mark the lnstitutional Biosafety Committee (IBC) attribute and upload your IBC provisional approval letter if your research requires IBC review.

Please Note: If the IBC provisional approval letter is missing from your submission, your IRB approval will be withheld until the IRB receives the provisional IBC approval letter. If you have the IBC # and date of IBC approval, you may include that information with your provisional approval letter.